A research team at the University of Virginia Health has made an exciting discovery that could lead to new treatments for ...

U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...

A combination of two widely available drugs could significantly reduce deaths from heart attacks, a study has found.  New ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...

Conditions such as pregnancy-related complications, menopause, and hormonal fluctuations influence woman's heart health. Read ...

The risk of dying from heart complications is significantly higher in the first 2 years after a colorectal cancer diagnosis, ...

Colon cancer is the second leading cause of cancer deaths in the U.S., and a new study shows it may also raise the risk of ...

Lp(a)] plays a key role in assessing cardiovascular risk, making awareness efforts equally essential for prevention and early intervention.

A new review highlights how gut microbiome imbalances contribute to cardiovascular disease by altering short-chain fatty ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.

Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...